Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in β-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat

Circulation

Volumn 110, Issue 16, 2004, Pages 2368-2375

  Bendall, Jennifer K ^a   Damy, Thibaud ^a   Ratajczak, Philippe ^a   Loyer, Xavier ^a   Monceau, Virginie ^a   Marty, Isabelle ^b   Milliez, Paul ^a   Robidel, Estelle ^a   Marotte, Françoise ^a   Samuel, Jane Lise ^a   Heymes, Christophe ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b CEA GRENOBLE   (France)

Author keywords

Contractility; Heart failure; Nitric oxide synthase; Receptors, adrenergic,

Indexed keywords

BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CAVEOLIN 3; CELL PROTEIN; DOBUTAMINE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; RYANODINE RECEPTOR;

ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; AUTOCRINE EFFECT; BETA ADRENERGIC STIMULATION; COMPLIANCE (PHYSICAL); CONTROLLED STUDY; EX VIVO STUDY; GENE TRANSLOCATION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE DP-DT; HEART MUSCLE; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE RELAXATION; IN VIVO STUDY; MALE; NONHUMAN; OXIDATIVE STRESS; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SARCOLEMMA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

EID: 6444242933     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000145160.04084.AC     Document Type: Article

References (24)

1. Massion PB, Feron O, Dessy C, et al. Nitric oxide and cardiac function: ten years after, and continuing. Circ Res. 2003;93:388-398.
2. Xu KY, Huso DL, Dawson TM, et al. Nitric oxide synthase in cardiac sarcoplasmic reticulum. Proc Natl Acad Sci USA. 1999;96:657-662.
3. Barouch LA, Harrison RW, Skaf MW, et al. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature. 2002;416:337-339.
4. Damy T, Ratajczak P, Robidel E, et al. Up-regulation of cardiac nitric oxide synthase 1-derived nitric oxide after myocardial infarction in senescent rats. FASEB J. 2003;17:1934-1936.
5. Damy T, Ratajczak P, Shah AM, et al. Increased neuronal nitric oxide synthase-derived NO production in the failing human heart. Lancet. 2004;363:1365-1367.
6. Khan SA, Skaf MW, Harrison RW, et al. Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthases. Circ Res. 2003;92:1322-1329.
7. Drexler H, Hornig B. Endothelial dysfunction in human disease. J Mol Cell Cardiol. 1999;31:51-60.
8. Ashley EA, Sears CE, Bryant SM, et al. Cardiac nitric oxide synthase 1 regulates basal and β-adrenergic contractility in murine ventricular myocytes. Circulation. 2002;105:3011-3016.
9. Sears CE, Bryant SM, Ashley EA, et al. Cardiac neuronal nitric oxide synthase isoform regulates myocardial contraction and calcium handling. Circ Res. 2003;92:e52-e59.
10. Bartunek J, Shah AM, Vanderheyden M, et al. Dobutamine enhances cardiodepressant effects of receptor-mediated coronary endothelial stimulation. Circulation. 1997;95:90-96.
11. 2+ in intact cardiac myocytes. Circ Res. 1994;74:970-978.
12. Paulus WJ, Vantrimpont PJ, Shah AM. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans: assessment by bicoronary sodium nitroprusside infusion. Circulation. 1994;89:2070-2078.
13. Wittstein IS, Kass DA, Pak PH, et al. Cardiac nitric oxide production due to angiotensin-converting enzyme inhibition decreases β-adrenergic myocardial contractility in patients with dilated cardiomyopathy. J Am Coll Cardiol. 2001;38:429-435.
14. Lew WY, Ryan J, Yasuda S. Lipopolysaccharide induces cell shrinkage in rabbit ventricular cardiac myocytes. Am J Physiol. 1997;272: H2989-H2993.
15. Razani B, Woodman SE, Lisanti MP. Caveolae: from cell biology to animal physiology. Pharmacol Rev. 2002;54:431-467.
16. Schwencke C, Okumura S, Yamamoto M, et al. Colocalization of β-adrenergic receptors and caveolin within the plasma membrane. J Cell Biochem. 1999;75:64-72.
17. Hare JM, Lofthouse RA, Juang GJ, et al. Contribution of caveolin protein abundance to augmented nitric oxide signaling in conscious dogs with pacing-induced heart failure. Circ Res. 2000;86:1085-1092.
18. Stamler JS, Meissner G. Physiology of nitric oxide in skeletal muscle. Physiol Rev. 2001;81:209-237.
19. Song KS, Scherer PE, Tang Z, et al. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells: caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem. 1996;271:15160-15165.
20. Xu L, Eu JP, Meissner G, et al. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science. 1998;279:234-237.
21. 2+ release in cardiomyocytes. Nat Cell Biol. 2001;3:867-873.
22. Zahradnikova A, Minarovic I, Venema RC, et al. Inactivation of the cardiac ryanodine receptor calcium release channel by nitric oxide. Cell Calcium. 1997;22:447-454.
23. Schuh K, Uldrijan S, Telkamp M, et al. The plasma membrane calmodulin-dependent calcium pump: a major regulator of nitric oxide synthase I. J Cell Biol. 2001;155:201-205.
24. Liu L, Hausladen A, Zeng M, et al. A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans. Nature. 2001;410:490-494.